Sowell Financial Services LLC Vertex Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $902,937 - $1.03 Million	3,188 New	3,188 $1 Million
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $474,162 - $559,161	-2,529 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $17,182 - $20,028	83 Added 3.39%	2,529 $539,000
Q4 2020 Jan 13, 2021	BUY	$207.01 - $276.09 $58,583 - $78,133	283 Added 13.08%	2,446 $578,000
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $2,045 - $2,424	8 Added 0.37%	2,163 $589,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $82,976 - $108,854	368 Added 20.59%	2,155 $626,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $173,799 - $215,594	-870 Reduced 32.74%	1,787 $425,000
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $81,521 - $109,491	489 Added 22.56%	2,657 $581,000
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $68,154 - $76,706	410 Added 23.32%	2,168 $367,000
Q4 2018 Mar 05, 2019	BUY	$151.91 - $192.21 $60,915 - $77,076	401 Added 29.55%	1,758 $291,000
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $8,386 - $9,637	50 Added 3.83%	1,357 $262,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $190,456 - $222,137	1,307 New	1,307 $229,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.